FGL2 and Fulminant hepatitis: Fgl2 prothrombinase is known to play a critical role in the hepatocellular injury observed in both MHV-3-induced fulminant hepatitis and human severe hepatitis B. Thus, human Fgl2/fibroleukin (hfgl2) was proposed as a target for therapeutic intervention [26].